Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | CFTR | P13569 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | CETP | P11597 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17489017 | 0.90 | MEN1 (0.53) | MEN1KMT2ASMN1; SMN2HIF1AALDH1A1 | |
| SCHEMBL17489014 | 0.82 | CFTR (0.55) | MEN1KMT2ASMN1; SMN2ALDH1A1CFTR | |
| SCHEMBL17488929 | 0.82 | CFTR (0.64) | MEN1KMT2ASMN1; SMN2ALDH1A1CFTR | |
| SCHEMBL17488937 | 0.81 | CFTR (0.64) | MEN1KMT2ASMN1; SMN2ALDH1A1CFTR | |
| SCHEMBL17490965 | 0.80 | MEN1 (0.49) | MEN1KMT2ASMN1; SMN2HIF1AALDH1A1 | |
| SCHEMBL17488964 | 0.80 | ALDH1A1 (0.49) | MEN1KMT2ASMN1; SMN2HIF1AALDH1A1 | |
| SCHEMBL28853905 | 0.79 | MEN1 (0.50) | MEN1KMT2ASMN1; SMN2HIF1AALDH1A1 | |
| SCHEMBL17490972 | 0.78 | MEN1 (0.51) | MEN1KMT2ASMN1; SMN2HIF1AALDH1A1 | |
| SCHEMBL19189364 | 0.78 | CETP (0.49) | MEN1KMT2ASMN1; SMN2TSHRRECQL | |
| SCHEMBL14390733 | 0.78 | CETP (0.49) | MEN1KMT2ASMN1; SMN2TSHRRECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9826129-B2 | Near-infrared-ray-absorbing composition, near-infrared-ray cut filter using same, manufacturing method therefor, camera module, and manufacturing method therefor | FUJIFILM CORPORATION (JP) | 2017-11-21 | — | — | US | disclosed |
| US-20160037034-A1 | NEAR-INFRARED-RAY-ABSORBING COMPOSITION, NEAR-INFRARED-RAY CUT FILTER USING SAME, MANUFACTURING METHOD THEREFOR, CAMERA MODULE, AND MANUFACTURING METHOD THEREFOR | FUJIFILM CORPORATION (JP) | 2016-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160037034-A1 | NEAR-INFRARED-RAY-ABSORBING COMPOSITION, NEAR-INFRARED-RAY CUT FILTER USING SAME, MANUFACTURING METHOD THEREFOR, CAMERA MODULE, AND MANUFACTURING METHOD THEREFOR | FAR1, SLC39A11, NOTUM | MEN1 315/4885KMT2A 2726/4885SMN1; SMN2 3862/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.